Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gion

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Anticancer Research|March 1, 1994
Biochemical parameters for prognostic evaluation in patients with breast cancerM Gion, R Mione, G L Pappagallo, et al.
Experimental Oncology|July 14, 2006
Reporting recommendations for tumor marker prognostic studies (remark)L M McShane, D G Altman, W Sauerbrei, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Variability of tumor markers in the follow-up of patients radically resected for breast cancerM Gion, G Cappelli, R Mione, et al.
International Journal of Oncology|November 24, 1999
Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinomaM Toi, M Gion, H Saji, et al.
Breast Cancer Research and Treatment|November 1, 1990
Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancerM Gion, R Mione, C Gatti, et al.
Tumori|August 31, 1990
Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCAM Gion, R Mione, C Gatti, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 casesM Gion, R Mione, A E Leon, et al.
Oncology|January 11, 2001
Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosisG Gasparini, M Toi, E Biganzoli, et al.
British Journal of Cancer|August 18, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)L M McShane, D G Altman, W Sauerbrei, et al.
The International Journal of Biological Markers|February 10, 2009
A prediction model for breast cancer recurrence after adjuvant hormone therapyP Boracchi, D Coradini, S Antolini, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Anticancer Research|March 1, 1994
Biochemical parameters for prognostic evaluation in patients with breast cancerM Gion, R Mione, G L Pappagallo, et al.
Experimental Oncology|July 14, 2006
Reporting recommendations for tumor marker prognostic studies (remark)L M McShane, D G Altman, W Sauerbrei, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Variability of tumor markers in the follow-up of patients radically resected for breast cancerM Gion, G Cappelli, R Mione, et al.
International Journal of Oncology|November 24, 1999
Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinomaM Toi, M Gion, H Saji, et al.
Breast Cancer Research and Treatment|November 1, 1990
Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancerM Gion, R Mione, C Gatti, et al.
Tumori|August 31, 1990
Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCAM Gion, R Mione, C Gatti, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 casesM Gion, R Mione, A E Leon, et al.
Oncology|January 11, 2001
Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosisG Gasparini, M Toi, E Biganzoli, et al.
British Journal of Cancer|August 18, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)L M McShane, D G Altman, W Sauerbrei, et al.
The International Journal of Biological Markers|February 10, 2009
A prediction model for breast cancer recurrence after adjuvant hormone therapyP Boracchi, D Coradini, S Antolini, et al.
Pageof 13